Enveric Biosciences Inc vs First Trust NASDAQ Clean Edge Green Energy Idx Fd — how do they compare? Enveric Biosciences Inc trades at $1.48 (market cap $6.80M), while First Trust NASDAQ Clean Edge Green Energy Idx Fd trades at $48.32 (market cap $561.25M). The key difference: First Trust NASDAQ Clean Edge Green Energy Idx Fd is far larger — about 82.5× Enveric Biosciences Inc's market cap, and First Trust NASDAQ Clean Edge Green Energy Idx Fd is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enveric Biosciences Inc for 14 Days and First Trust NASDAQ Clean Edge Green Energy Idx Fd for 50 Days on average.
| ENVB | QCLN | |
|---|---|---|
Market Cap | $6.80M | $561.25M |
Volume | 64,867 | 323,550 |
Sector | Health | Sector/Thematic |
52-Week High | $10.80 | $68.47 |
52-Week Low | $1.27 | $41.10 |
Typical Hold Time | 14 Days | 50 Days |
Enterprise Value | -$1.49M | — |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.48, down 1.0% today, with a bearish technical signal from moving averages but neutral oscillators. The company shows negative profitability with ROE at -235.48% and ROA at -193.53%, though it has beaten EPS expectations for four consecutive quarters. Recent developments include patent allowances for non-hallucinogenic therapeutics and positive preclinical data for EB-003.
While analyst consensus is 75% buy with no sell ratings, fundamental weaknesses in revenue generation and negative cash flow from operations pose significant risks. The stock's appeal hinges on clinical progress and regulatory milestones, making it suitable for risk-tolerant investors betting on biotech innovation amid high operational and financial volatility.
QCLN trades at $49.44, down 2.62% today but maintains a bullish technical outlook with strong moving average support. The clean energy ETF benefits from geopolitical tensions accelerating renewable energy adoption globally. Recent news highlights increased data center energy demand and political focus on clean energy policies as key growth catalysts.
The ETF's performance remains tied to U.S. political outcomes and federal energy policy, with recent outperformance against major indices. Key risks include policy uncertainty and market volatility, while institutional interest grows amid global energy security concerns and the ongoing energy transition.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →QCLN invests in U.S.-listed companies engaged in clean energy technologies. It focuses on solar power, wind, electric vehicles, and energy storage, with major holdings in firms like Tesla, ON Semiconductor, and Rivian.
Read more on QCLN →